Dentin caries is a common oral disease that affects millions of people worldwide. It is caused by the demineralization of the tooth structure, leading to the formation of cavities in the dentin layer of the tooth. If left untreated, dentin caries can progress and cause pain, infection, and tooth loss. Alta Stomatology is a leading oral disease research company dedicated to developing reagents and drugs for the prevention and treatment of dentin caries. 

In recent years, there have been significant advancements in the research and development of drugs targeting dentin caries. Novel drug candidates are under investigation, with a focus on antimicrobial agents that target specific bacterial strains linked to caries. These agents aim to combat the microbial that cause dentin caries effectively. Additionally, researchers are exploring bioactive materials designed to release minerals, fostering remineralization processes crucial for strengthening tooth structure.